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Abstract. An overview of the fluorophores of the eye, the methods
used to measure ocular fluorescence, and the existing or ready-to-
market instrumentation for the early diagnosis and monitoring of oph-
thalmic pathologies is presented. Emphasis is given to the impact that
a more detailed knowledge of the fluorophores of the eye, their age
and pathology relationship, and the considerable technology-driven
progress in optical devices and components has had on the develop-
ment of new compact yet powerful instruments for population screen-
ing and for patient follow-ups, using fluorometry alone or in combi-
nation with other optical techniques such as light scattering. © 2004
Society of Photo-Optical Instrumentation Engineers. [DOI: 10.1117/1.1628241]
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Ocular pathologies such as diabetic retinopathy, glaucoma,
and cataract represent the most frequent cause of blindness in
the Western world. This is more and more evident in a society
characterized by a constant increase in the population’s aver-
age age, since most of the these pathologies are age related.
Therefore, a considerable effort has to be spent in developing
means to prevent the onset of sight-impairing pathologies, and
to monitor their evolution in a qualitative or even quantitative
way, even at a very early stage. The techniques and instru-
ments used should then be accompanied by sophisticated,
possibly noninvasive, surgical tools aimed at the treatment of
ocular disturbances with minimal burden to the patient.
An increasingly outstanding role has been played in the
past few years by instruments and techniques able to provide
diagnostic aids to the surgeon, to clearly define degrees of
severity of the disease, to identify high-risk populations, and
to assess the validity of therapy through the control of drug
pharmacokinetics.
Most ocular media and tissues exhibit fluorescence emis-
sion upon excitation by suitable wavelengths of light. A large
variety of these ocular fluorophores exhibit marked changes in
their fluorescence properties with respect to age and pathol-
ogy. Thus, the biological and functional properties of many
ocular media and tissues and their modifications are indicators
of aging or disease and can be used as diagnostic tools.
In addition to naturally existing ocular fluorophores, a
number of other fluorescing compounds may be present in the
eye. Their presence can be either intentional or noninten-
tional. The former case includes all fluorescing drugs that are
delivered to the eye for specific diagnostic purposes ~e.g., as a
contrast marker in fluoroangiography and fluorophotometry!.
The latter case includes all fluorescing compounds that are
present in the eye as a consequence of diagnostic or therapeu-
tic purposes outside the eye, and that can accumulate in the
eye after crossing the ocular barriers. A third, less-studied
category of fluorophores is that of vitreous substitutes. Vitre-
ous substitutes are substances ~in general, polymers or solu-
tions! that are inserted into the eye for vitreal surgery. The
fluorescence properties of these compounds are a secondaryJourn
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fluorometry.
For both types of fluorophores, endogenous and exog-
enous, ocular fluorometry as a diagnostic technique is in gen-
eral facilitated by the light transmission properties that the
eye, as a vision organ, exhibits at most of the wavelengths of
interest for fluorophore excitation and fluorescence detection
~with the exception of the UV range!. However, the ease of
penetration of light through the ocular tissues raises strict re-
quirements of selectivity for fluorophore discrimination.
The evolution of technology in optics, electronics, and op-
toelectronics has produced a tremendous amount of new light
sources, detectors, modulators, and electronic circuits for sig-
nal analysis and elaboration. These can be viewed as the
building blocks of a new generation of easy-to-use, powerful,
and yet fairly compact and inexpensive instruments for the
measurement of ocular fluorescence both in vitro and in vivo.
Together with the ‘‘traditional’’ systems for ocular fluorom-
etry, such as the well-known Fluorotron Master, new exciting
clinical instruments have been put on the market, or are at an
advanced state of development and engineering, almost ready
for commercialization. In addition, when fluorometry is not
itself sufficient for gathering adequate diagnostic information,
it can be efficiently combined with other optical measurement
techniques ~static or dynamic light scattering, or Raman spec-
troscopy, are typical examples!, thus providing an integrated
multisensor approach. The Laboratory of Optoelectronics in
Brescia, and the new Laboratory of Optoelectronics in
Modena, are active in the development, characterization, and
preclinical testing of systems for ophthalmic diagnosis using
fluorometry, light scattering, and interferometry. This work is
done in close collaboration with important laboratories at a
national and international level.
This paper gives an overview of the state of the art of
methods and instruments for fluorescent measurements in the
eye, alone or with multisensor approaches. Section 2 is de-
voted to an overview of natural fluorophores, discussing their
significance in relation to their application in ophthalmic di-
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Rovati and DocchioFig. 1 A Jablonski diagram illustrates the basic mechanisms of fluo-
rescence. Excited electrons remain in the excited state (S1 and S2) on
a time scale of nanoseconds, then return to the ground state (S0).
When photons are emitted, their wavelengths are longer (lower fre-
quency) and consequently they are less energetic than the photons
responsible for the excitation, owing to energy loss (nonradiative tran-
sition) by the molecule prior to emission.agnosis using fluorometry. Section 3 focuses on traditional
and innovative fluorometric methods and instruments, and
Sec. 4 describes the most significant diagnostic methods that
use fluorescence measurements in the various eye compart-
ments.
2 Natural Fluorescence of Ocular Tissues
2.1 Basic Mechanisms
Fluorescence is luminescence characterized by an emission of
light on a short time scale after excitation. Light is absorbed
by the fluorophores in femtoseconds, causing electrons to be-
come excited to a higher electronic state. The electrons re-
main in the excited state for nanoseconds, then return to the
ground state. Energy is emitted as the electrons return to their
ground state. The whole process is frequently illustrated using
the Jablonski diagram1 shown in Fig. 1. For the most relevant
molecules of interest, the lowest energy state, the ground
state, is a singlet. This is normally represented as S0 , and the
various excited states of the same multiplicity are shown as
S1 , S2 , S3 , etc. Each state includes various vibrational levels
~four in Fig. 1!. As noted by Vavilov2 and Kasha,3 the fluo-
rescence of ocular molecules normally involves a transition
from the lowest vibrational level of the lowest excited elec-
tronic state. When photons are emitted, their wavelengths are
longer ~lower frequency! and consequently are less energetic
than the photons responsible for the excitation; this is due to
energy loss by the molecule prior to emission.4 This differ-
ence between excitation and emission maxima is termed the
Stokes shift.
The Stokes shift represents the mean energy lost while the
molecule was in the excited state. The Stokes shift is impor-
tant for many reasons, but from a practical point of view, it
allows the emitted fluorescent photons to be easily distin-
guished from the excitation photons, leading to the possibility
of very low backgrounds in fluorescence studies. A second
important result is that the vibrational spacings in the ground
(S0) and lowest excited (S1) states are often very similar;
therefore a mirror image is often observed between the exci-
tation and emission spectra when they are plotted as functions
of the optical frequency. As an example, we show in Fig. 2 the10 Journal of Biomedical Optics d January/February 2004 d Vol. 9 No.
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natural ocular fluorophores: the tryptophan.5
An important parameter in fluorometry is the quantum
yield of fluorescence, defined as
F5
Ne
N f
, ~1!
where N f is the number of absorbed photons and Ne is the
number of photons emitted as fluorescence. The yield of fluo-
rescence depends upon the dynamics of the decay of the ex-
cited state caused by other competing reactions.
A spectral shift toward the red makes it possible to excite a
fluorophore over a narrow spectral band and detect a much
weaker fluorescence by excluding the reflected and scattered
excitation using a suitable narrowband filter. The limits of
detection of a fluorescence signal depend mainly on the prop-
erties of the fluorophores. A detectability to parts per billion
or even parts per trillion is common for most analytes. This
extraordinary sensitivity allows the reliable detection of very
low concentrations of fluorescent molecules.
Fluorescence measurements can be highly specific since,
even if different compounds may absorb and emit light, it is
rare that their emitted light spectra overlap completely with
the spectrum of the light emitted by the target fluorophore.
Moreover, fluorescence intensity is linear with fluorophore
concentration over a very broad range. Thus, fluorometry can
be used over three to six decades of concentration according
to instrumentation dynamics.
2.2 Overview of the Ocular Endogenous
Fluorophores
Most ocular media emit natural fluorescence upon suitable
excitation. The accumulation of natural fluorescent proteins in
ocular tissue can result from exposure to ambient light6,7 or to
ocular pathologies.8 As stated earlier, in addition to naturally
existing ocular fluorophores, a number of other artificial fluo-
rescing compounds may be present in the eye. They can be
either intentional ~e.g., as a contrast marker in fluoroangiog-
raphy! or nonintentional ~e.g., fluorescing compounds used
for diagnostic or therapeutic purposes that, after crossing the
ocular barriers, accumulate in the eye!. This section focuses
Fig. 2 Extinction coefficient and fluorescence emission spectrum of
tryptophan dissolved in water, 0.1 M phosphate buffer, pH 7 using an
excitation wavelength of 270 nm. Note that the extinction and the
emission spectra are mirrored.1
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fluorophores ~autofluorescent compounds!. These fluoro-
phores are visible in the cornea, lens, vitreous body, and reti-
nal pigment epithelium ~RPE!. In the next sections, ocular
endogenous fluorophores located among the different ocular
tissues are presented. Table 1 summarizes the main character-
istics of the fluorophores described.
2.2.1 Cornea
Corneal autofluorescence was demonstrated to originate from
flavoproteins and pyridine nucleotides as a result of metaboli-
cally impaired corneal mitochondrial respiration.9 Endog-
enous fluorophores in the cornea are located in the corneal
epithelium and endothelium. These fluorophores are mainly
flavoproteins ~flavine adenine dinucleotide or FAD, and flavin
mononucleotide or FMN! and pyridine nucleotides ~nicotina-
mide dinucleotide or NAD and nicotinamide dinucleotide
phosphate or NADP!.9,10
The flavoproteins fluoresce in their oxidized form ~FAD
and FMN! with an excitation maximum at lex5450 nm and
an emission maximum at lem5550 nm, whereas pyridine
nucleotides fluoresce in the reduced state ~NADH and
NADPH; lex5366 nm and lem5450 nm).
Fluorescence of the cornea can also originate from glyco-
sylated collagen via the Maillard reaction.11 The excitation
maximum of collagen-linked fluorescence is 370 nm, with an
emission maximum at 440 nm.9
2.2.2 Cristallin lens
The a, b, and g crystallins in the lens exhibit tryptophan
fluorescence (lex5295 nm and lem5329 nm). The distribu-
Table 1 Main characteristics of the ocular endogenous fluorophores.
Ocular Tissue
Endogenous
Fluorophores
Excitation and
Emission
Wavelengths (nm)
Cornea Flavoproteins lex5450
lem5550
Pyridine
nucleotides
lex5366
lem5450
Glycosylated
collagen
lex5370
lem5440
Cristallin lens Tryptophan lex5295
lem5329
Nontryptophan lex5364 to 472
lem5437 to 523
Hydroxy-
kynurenine
glucoside
lex5520
lem5550
Vitreous body — —
Retinal pigment
epithelium
Lipofuscin lex5300
lem5420
Melanolipofuscin lex5364
lem5540Journa
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the lens cross-section,12 mirroring the distribution of
proteins.13 Nontryptophan fluorophores are not present in the
newborn and fetal lenses.14
Lens aging favors protein bonds and thus there is an in-
creased amount of water-insoluble protein fractions ~up to
40% of the overall amount of lens proteins!.15 The develop-
ment and accumulation of nonsoluble protein fractions in the
lens have been demonstrated to be the result of cross-linking
of water-soluble proteins through photo-oxidation processes.
Photo-oxidation leads to disulfide or other bonds that are sup-
posed to be initiated by the combined action of long-
wavelength UV light and endogenous photosensitizers such as
kynurenine and bityrosine.14,16,17 Consequently, nontryp-
tophan fluorescence develops and increases with age.14,18,19
Besides photochemical processes, metabolic processes may
contribute in part to the buildup of nontryptophan
fluorescence.16,19,20 Excitation and emission spectra of non-
tryptophan fluorescence exhibit peaks at longer wavelengths
than tryptophan; typically lex5364 to 472 nm and lem
5437 to 523 nm. Nontryptophan fluorescence is markedly
nonuniform throughout the lens, decreasing from the outer-
most layers to the nucleus with axial symmetry.12,21
Fluorescence of the lens can also originate from the glu-
coside of hydroxykynurenine ~3-HGK!, which is a
nonprotein-bound, nontryptophan fluorophore present even in
young eyes.16 The excitation maximum of the glucoside of
hydroxykynurenine fluorescence is 520 nm, with an emission
maximum at 550 nm.22
2.2.3 Vitreous body
The literature does not report on the fluorescence properties of
vitreous, which is currently considered as nonfluorescent in
the visible. However, there is evidence of fluorescence exhib-
ited by vitreous, especially in older eyes, as well as of age-
related modifications of these fluorescence properties. To our
knowledge, no attempt has been made to identify the nature of
the fluorophores of the vitreous.
2.2.4 Retinal pigment epithelium
Fluorescence of the retinal pigment epithelium is mainly re-
lated to lipofuscin. Intact human lipofuscin granules exhibit a
broadband excitation spectrum from 300 to about 420 nm, and
an emission spectrum that peaks in the yellow-orange region
of the spectrum. Both excitation and emission spectra are age
related.23,24
Melanin is the other main chromophore of the RPE; it is
generally considered as nonfluorescent. However, studies on
melanin granules in vitro showed age-related fluorescence
properties, probably due to some combination with lipofuscin.
The excitation maximum of melano-lipofuscin fluorescence is
364 nm, with an emission maximum at 540 nm.22
3 Instrumentation for Ocular Autofluorescence
Measurements
3.1 State of the Art
Ophthalmic diagnostic methods are based on the well-known
continuous wave ~cw! technique for analytical in vitro tests:
single-point measurements and image measurements. In the
following paragraphs, some of the best-established instrumen-l of Biomedical Optics d January/February 2004 d Vol. 9 No. 1 11
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Diagnostic Method
Laboratory or Commercial
Instrument Excitation Source Emission Detector
Ocular Tissue
Investigated
Axial-scanning fluorometry
(ASF)
Fluorotron Master
(Ocumetrics, Inc.)
Halogen lamp Single-photon counting
photomultiplier tube
Axial scan of the ocular
axis (from retina to
cornea)
Imaging ocular fluorometry
(IOF)
Modified slit lamp
Scheimpflug camera
(Topcon SL45)
Halogen lamp
Halogen lamp
Analog photodetector or
camera
CCD cameras
Cornea and
cristallin lens
Confocal imaging fluorometry
(CIF)
Laser scanning
ophthalmoscope
(Heidelberg Engineering)
Lasers Photomultiplier tube or
photodiode
Retinal pigment
epithelium
Optical multichannel analyzer
(OMA)
Modified slit lamp Halogen lamp Multichannel
photodetector
Cristallin lens
Corneal fluorometry (CF) Portable instrument
developed by the Laboratory
of Optoelectronics
(University of Brescia)
Light-emitting diodes
(LEDs)
Analog photomultiplier
tube
Cornea
Autofluorescence combined with
dynamic light scattering
(AF1DLS)
Integrated instrument
developed by the Laboratory
of Optoelectronics
(University of Brescia)
Halogen lamp and laser Single-photon-counting
photomultiplier tube and
single-photon-counting
avalanche photodiode
Axial scan of the ocular
axis (from retina to
cornea)tation performing in vivo autofluorescence measurements is
presented. Table 2 summarizes the main characteristics of
these instruments.
3.1.1 Axial-scan fluorometry
Axial-scanning fluorometric ~ASF! techniques detect autof-
luorescence intensity as a function of the scanning coordinate
to quantify alterations in ocular tissues. While various systems
have been suggested, probably the most popular is that sug-
gested by Zeimer et al.25 and commercially available as the
Fluorotron Master ~FM; Ocumetrics Inc., California!. This
system was originally designed to measure fluorescein within
the eye. Basically, the output data are the fluorescein concen-
tration profile along the optical axis ~from retina to cornea!.
As shown in previous studies,26 the excellent sensitivity of the
FM also makes it suitable for measuring autofluorescence of
the ocular tissues. The system sends a focused excitation
beam of blue light into the eye and then detects the resulting
naturally fluorescent green light. In the standard operation
mode, up to 149 sequential measuring positions are explored
along the ocular axis. The measuring range is 37 mm, which
is sufficient to scan the eye from the retina to the cornea,
whereas the scanning spatial resolution is 0.25 mm. The ex-
citation source consists of a tungsten light source followed by
the excitation bandpass filters ~440 to 480 nm!. The medical
operator can scan the patient’s ocular axis from the retina to
the cornea. The resulting natural fluorescence is collected by
the same lens system and guided to the emission optical filter
~530 to 630 nm!. The filtered optical signal is detected by a
photomultiplier tube operating in a single-photon counting
mode. By means of suitable calibration tools, including plastic
fluorescent samples, the instruments readings are provided di-
rectly in terms of concentration of fluorescein.12 Journal of Biomedical Optics d January/February 2004 d Vol. 9 No.
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The most popular imaging ocular fluorometry ~IOF! tech-
niques are based upon modification of standard slit-lamp pho-
tographic techniques. The slit lamp, usually a halogen lamp
equipped with suitable filters, is used as the excitation source.
The fluorescent emission is imaged onto the detector or the
camera, which is placed at an angle with respect to the direc-
tion of incidence of the light. For obvious reasons, this
method is restricted to the anterior chamber and the lens, and
is commonly used to monitor and record corneal and lenticu-
lar fluorescence. For some clinical applications, the fluores-
cence from one point of the lens section is assumed to be
directly related to the amount of light reaching that point; in
this case, fluorescence is used to monitor lens transmission
and its age and pathology relationship.
Another important IOF technique is based on Scheimpflug
photography. The optical axis of the excitation light and the
axis of the film and detector equipment are parallel to each
other. A long depth-of-field objective located at an angle with
respect to the axis of the excitation light is used to image the
scatter or fluorescence from the lens onto the film.27,28 The
Topcon SL45 camera, modified for Scheimpflug photographs,
is the current instrument available for fluorescence imaging.
Microdensitometric analysis and computer analysis of the
photographs,29 or direct digital acquisition using CCD
cameras,30 are used to provide a digital representation of the
images.
Scheimpflug photography is at present becoming a stan-
dard method for monitoring modifications of the lens fluores-
cence in relation to age and cataract formation.31–33 This is
normally correlated with visible Scheimpflug densitometry to
monitor lens opacification and scattering.34,351
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In the confocal imaging fluorometer ~CIF!, the excitation light
is focused in a small area and the collection optics images this
area on the sensitive area of the photodetector. A complete
characterization of the collection optics can be performed by
replacing the detector with an appropriate light source and
defining the observation beam in this way. The volume under
test is defined by the overlap between the excitation and the
observation beam in the focus position. To obtain fluorescence
images, the illuminated area and the observation beam scan
the region of interest. For confocal fluorometry, laser light is
more advantageous than lamp light, since a higher spatial
resolution is achievable.
Recently several confocal fluorescence measurements have
been performed using laser scanning ophthalmoscopes ~LSO!
or near-field scanning microscopes.36,37 These instruments
usually integrate different excitation lasers, e.g., argon lasers
(l5488 and 514 nm!, helium:neon ~He:Ne! lasers (l
5633 nm), and laser diodes (l5680 to 900 nm!. In addition,
two to four confocal diaphragms, acousto-optical modulation
of the laser beam, and ametropia correction are used to obtain
excellent fluorescent mapping in different conditions.
3.2 Artifacts in Autofluorescence Measurements
In vivo ocular fluorometric techniques base their effectiveness
on the ability to couple excitation light of a suitable wave-
length to the target, and to detect the fluorescent emission
from the target area in a sensitive and selective way.
The first instrumental artifacts observed during fluores-
cence measurements are related to stray light in the measuring
system38 and to ambient light. Moreover, during the aging of
the excitation source, the intensity of its radiation decreases
and its spectral composition may change. Fluctuations in
power supply can also result in different levels of brightness
and spectral variations. These may affect the measurements,
since autofluorescence intensity is proportional to the inten-
sity of the exciting radiation. Therefore great care should be
taken to monitor the excitation optical power and spectrum.
On the other hand, the detectors also could present different
sensitivity during aging. This factor is more difficult to moni-
tor.
Another important factor affecting fluorescence measure-
ments is the fraction of the excitation beam back-reflected in
the optical path of the emission by interfaces. Even if this
light has the same wavelength as the excitation beam and thus
is stopped by the emission filter, this radiation could interfere
with the measurement in the case of weak fluorescence sig-
nals, e.g., corneal fluorescence. Another unwanted contribu-
tion to the fluorescence signal comes from Raman scattering.
In this case, a small part of the excitation scattered light is at
longer wavelengths. This light is not stopped by the emission
filter, and therefore the distinction between autofluorescence
and Raman scattering could be a problem.
A last important contribution affecting measurements of
fluorescence intensities is related to the attenuation of the ex-
citation light beam in the optical path by the ocular tissue
under test ~inner-filter effect39!. This leads to a nonlinear re-
lation between fluorescence intensity and fluorophore concen-
tration and, at sufficiently high concentrations, to an apparent
fluorescence quenching.Journa
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be critical. Autofluorescence measurements may require a
long measuring time; therefore spatial resolution could be
largely compromised by eye movements. Moreover, unwanted
ocular tissues could contribute to the total fluorescence signal
detected.
3.3 Instrument Requirements
Systems used for autofluorescence measurements are usually
highly reliable. However, measurement uncertainty and errors
should be considered when interpreting data. Sources of error
can be found in deficiencies of the device and/or have their
origin in eye movements.
Design efforts should be made to eliminate any transmis-
sion of reflected or scattered excitation light through the emis-
sion filter, which leads to pseudofluorescence. The instrument
should use high-quality interference filters for setting the
wavelengths of excited and emitted light. The overlap of their
transmission bands should be minimal. Munnerlyn et al.40
recommend increasing the separation between the excitation
and barrier filters to about 30 nm at the 50% transmission
points and possibly doubling both filters for maximum reduc-
tion in the overlap.
A calibration procedure is essential to correct for the alter-
ation through aging of the optical source and the detectors.
Standard calibration procedure exploits commercially avail-
able fluorescent solutions, e.g., fluorescein solutions of known
concentration and constant pH. This also offers the chance to
convert readings to units of concentration of fluorescein and
makes it easier to compare results with those obtained by
other researchers. Solid fluorescence phantoms often repre-
sent an excellent and stable calibration sample.41
In ocular fluorometry, the optical power of the excitation
must be kept within the maximum exposure limits recom-
mended by international standards, e.g., ANSI standards.42
However, a reduction in this optical power diminishes the
available fluorescence signal, thus increasing the minimum
detectable signal or increasing the time required to make a
measurement. The use of lasers improves ~1! the degree of
spatial resolution; ~2! the sensitivity; and ~3! the spectral reso-
lution, which allows unwanted contributions to fluorescence
and scattering to be eliminated. However, for diagnostic pur-
poses, gas lasers have so far found limited commercial appli-
cations because of their relatively high cost compared with
standard excitation sources ~lamps!. For this reason we be-
lieve the semiconductor coherent and incoherent sources to be
of great importance in future instrumentation for ocular fluo-
rometry. Recently, blue light-emitting diodes ~LEDs! have
been proposed for measurements of corneal
autofluorescence.41 Spot size and depth of focus of the exci-
tation beam should be designed to achieve the best spatial
resolution. This can be obtained by properly shaping the ex-
citation beam, e.g., reducing the width of the excitation dia-
phragm and increasing the angle between the exciting and the
emitted beam, which determines the depth of the ‘‘focal
diamond.’’ 40
The first requirement for the detection system is the front-
end electronics, which should be designed to maximize the
signal-to-noise ratio. Photon-counting detection techniques, in
which each photon represents a single digital pulse, are used
to effectively reduce noise and improve sensitivity. Thisl of Biomedical Optics d January/February 2004 d Vol. 9 No. 1 13
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tems, in which all of the signals are digitized and processed
by a computer. Photodetectors preferably should have internal
amplification of the signal. Modern solid-state technology of-
fers high-performance detectors, such as avalanche photo-
diodes ~APD!, to replace the standard photomultiplier tube
~PMT!.
Computerized systems improve the quality of the diagnosis
in ophthalmic practice by using the computational power and
storage capacity of the new personal computers. An auto-
mated comparison of two or more fluorescence signals can be
easily done by a computer. Software should be user friendly
and object oriented. Moreover, the system should not burden
the patient, and a suitable fixation aid should be implemented
before and during the measurement so that the eye is oriented
correctly with respect to the optical axis.
3.4 Outlook for New Systems and Techniques
3.4.1 Optical multichannel analyzer
A fluorescence spectrometer has been specially designed for
in vivo measurements of lens autofluorescence. It consists of a
modified slit lamp integrated with an optical multichannel
analyzer ~OMA!.43 Even if the first model is not recent, this
spectroscopic approach is still innovative for in vivo investi-
gation of interactions among the various fluorophores gener-
ated in the lens. The OMA offers high sensitivity and high
spectral resolution. Several studies in vitro have been per-
formed and published ~e.g., Refs. 43 and 44!. The system was
also used to perform in vivo measurement in various lens
conditions, as described in detail in Figs. 3~a!, 3~b!, and
3~c!.22
3.4.2 Corneal fluorometer
A portable corneal fluorometer ~CF! has been developed in
our laboratories. This instrument has been designed to mea-
sure the autofluorescence of the cornea.41 As shown in Fig.
4~a!, the laboratory prototype of the system is based on a
photographic camera equipped with a fluorescence excitation
adapter for the tangential illumination of the corneal tissue,
with appropriate excitation and barrier filters, and with a pho-
tomultiplier in the image plane of the camera for the detection
of the emitted fluorescence. To minimize the contribution of
the much higher fluorescence of the underlying crystalline
lens, special geometry and measurement procedures have
been designed.
To reduce costs, custom light-emitting diodes in combina-
tion with suitable, inexpensive color filters are used as the
excitation source. Custom signal-conditioning electronics has
been developed to treat the signal for subsequent conversion.
A single-chip microprocessor unit has been designed to con-
trol signal acquisition, to convert the acquired signal to digital
form, and to display the results. To add flexibility, the instru-
ment can be interfaced to a personal computer. Figure 4~b!
shows a typical tangential illumination of the cornea per-
formed on a bovine enucleated eye.
This portable corneal fluorometer may be successfully
used in the routine screening of populations at risk for dia-
betic retinopathy. The apparatus has proven to be very easy to
use, automatic, flexible, sensitive, linear, and repeatable.14 Journal of Biomedical Optics d January/February 2004 d Vol. 9 No.
Downloaded from SPIE Digital Library on 25 Mar 2010 Fig. 3 (a) Comparative spectra obtained in vivo upon excitation at
404 nm. (b) Comparative spectra obtained in vivo upon excitation at
436 nm. (c) Comparative spectra obtained in vivo upon excitation at
485 nm. (Reproduced from Ref. 22 with permission.)1
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Autofluorescence methods in ophthalmologyFig. 4 (a) Portable corneal fluorometer developed in the Laboratory of Optoelectronics of the University of Brescia. (b) Typical tangential illumi-
nation of the cornea performed on a bovine enucleated eye.3.4.3 Axial-scan fluorometer integrated with a
dynamic light-scattering analyzer
Dynamic light scattering ~DLS! is a technique for measuring
the random thermal movements of suspended particles, mac-
romolecule solutions, and other complex liquid systems.45
Our groups developed an integrated instrument based on the
FM modified to include the DLS setup.46 The instrument si-
multaneously investigates the autofluorescence and DLS
properties of the same ocular volume.
A block diagram of the optical setup is shown in Fig. 5~a!.
Optical integration between the autofluorescence and DLS
system is obtained using a couple of collimators and a couple
of dichroic mirrors. These mirrors, inserted between the fluo-
rescence unit and the scanning lens SL, separate the autofluo-
rescence and the DLS signals, offering a total reflectance to
the DLS laser wavelength and a total transmittance to the
autofluorescence excitation and emission beams. The DLS ex-
citation laser source emits radiation at wavelength of 670 nm.
The scattered light is detected by an avalanche photodiode.
Both the excitation laser light and the scattered light are
guided by single-mode optical fibers. Figure 5~b! shows the
integrated instrument.
4 Overview of Autofluorescence Diagnostic
Methods
As stated earlier, ocular pathologies such as diabetic retinopa-
thy, glaucoma, and cataract can induce changes in the fluores-Journa
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Thus the biological and functional properties of these tissues
and their modifications are indicators of aging or disease and
can be used as diagnostic tools. In the following paragraphs,
some of the best established diagnostic methods are pre-
sented. Table 3 summarizes the main characteristics of these
methods.
4.1 Corneal Autofluorescence
In 1990 Stolwijk47 first proved that the weak signal, compa-
rable to about 10 ng of fluorescein per milliliter, measured by
ASF in the axial position of the cornea did not originate from
excitation light scattered at the corneal surface, as previously
stated,48 but mainly originated in corneal autofluorescence.
The fluorescence arising from flavoproteins can give infor-
mation about the metabolic state of the cornea. A decreased
mitochondrial function, induced for instance by hypoxia, will
result in a decrease in the fluorescence signal of oxidized
flavoproteins.49 An increased metabolism will result in an in-
creased mitochondrial function, causing a higher fluorescence
of the oxidized flavoproteins.50
As a result of aging, the amount of glycosylation collagen
increases.47 Furthermore, in diabetic patients, an increase in
collagen fluorescence of the dura mater and skin was
found.51,52 The age-corrected, collagen-linked fluorescence in
the skin correlated well with duration of diabetes, degree of
retinopathy, arterial stiffness, and joint stiffness.Fig. 5 (a) Block diagram of the integrated instrument based on the Fluorotron Master modified to include the dynamic light-scattering setup. DM,
dichroic mirrors; SL, scanning lens; OBJ, objective; SPCM, single-photon counting module. (b) Picture of the integrated instrument. The instrument
simultaneously investigates the autofluorescence and dynamic light-scattering properties of the same ocular volume.l of Biomedical Optics d January/February 2004 d Vol. 9 No. 1 15
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Rovati and DocchioTable 3 Main characteristics of the autofluorescence diagnostic methods.
Ocular Tissue Investigated Pathology
Biochemical Mechanism
(P, proved,
S, speculative) Instrumentation Major References
Cornea Diabetes P: glycosylation of collagen ASF 47, 53, 54
Diabetic retinopathy S1: elevation of blood
glucose level induces
alterations in lipid and
protein metabolism
S2: neovascularization of
the iris (rubeosis iridis)
may reach the cornea
ASF, CF and AF1DLS General: 53, 54, 55
S1: 56
S2: 57
Open-angle glaucoma S: autonomic neuropathy
causing change in corneal
innervation and
consequently altering corneal
metabolism
ASF 63, 64, 65, 66
Penetrating keratoplasty S: surgical denervation ASF 67, 68
Cristallin lens Diabetes P: glycosylation of collagen ASF, IOF, and OMA 48, 78, 79
Cataract P: protein bonding ASF, IOF, and OMA 73, 74, 80
Retinal pigment epithelium Age-related maculopathy P: accumulation of
lipofuscin
CIF 89, 90
Senile macular
degeneration
P: accumulation of
lipofuscin
CIF 89
Retinitis pigmentosa P: accumulation of
lipofuscin
CIF 87
Sjo¨gren-Larsson
syndrome
P: accumulation of
lipofuscin
CIF 88Corneal autofluorescence was found to be not dependent
on age in healthy controls, non-insulin-dependent diabetes
mellitus ~NIDDM!, insulin-dependent diabetes mellitus
~IDDM!, and penetrating keratoplasty ~PKP! patients.47 As
shown in Fig. 6, the values for the NIDDM, IDDM, and pen-
etrating keratoplasty patients differed significantly from those
of the healthy controls ~131, 150, and 131%,
respectively!.4716 Journal of Biomedical Optics d January/February 2004 d Vol. 9 No.
Downloaded from SPIE Digital Library on 25 Mar 2010 Corneal autofluorescence was found to be strongly related
to the grade of retinopathy.53 Patients with negligible retin-
opathy or none ~grade 1! had about the same fluorescence
values as healthy controls.54
As shown in Fig. 7, an average increase of about 50.7% in
the corneal autofluorescence between patients with negligible
diabetic retinopathy ~grade 1! and those with proliferative dia-
betic retinopathy ~grade 4! was observed using a cornea fluo-
rometer whereas, considering only IDDM patients, an average
increase of about 95.8% in the corneal autofluorescence be-
tween diabetic retinopathy grade 1 and diabetic retinopathy
grade 4 patients was observed.55
The correlation between the grade of diabetic retinopathy
and corneal autofluorescence suggests, as a first explanation,
that the vascular component of diabetes mellitus causing spe-
cific microangiopathy and consequently progressive retinopa-
thy may be related to the metabolic disorder ~the elevation of
blood glucose level associated with alterations in lipid and
protein metabolism!.56 This metabolic disorder can also affect
the cornea, resulting in an increase in corneal autofluores-
cence. As a second explanation, neovascularization-mediating
substances produced in a retina with diabetic retinopathy that
induce neovascularization of the iris ~rubeosis iridis! may
reach the cornea as well and consequently induce changes inFig. 6 Corneal autofluorescence in healthy controls, diabetics (non-
insulin-dependent diabetes mellitus, NIDDM and insulin-dependent
diabetes mellitus, IDDM), and patients with penetrating keratoplasty
(PKP). The solid dots represent the mean values observed for each
group of patients; the bars are the standard deviations.1
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Autofluorescence methods in ophthalmologyFig. 7 Corneal fluorometer readings as a function of the retinopathy grade for the whole patient group (NIDDM and IDDM) (a) Corneal fluorometer
readings as a function of the retinopathy grade for IDDM patients. (b) Solid dots represent the mean values observed for each group of patients; the
bars are the standard deviations. (Reproduced from Ref. 55 with permission.)corneal metabolism, resulting in increased values of
autofluorescence.57
DLS combined with an axial-scan fluorometer (AF
1DLS) has been used to efficiently detect early stages of
diabetic retinopathy.57 Two DLS measurements in the poste-
rior part of the vitreous and one in the cornea were performed
in each eye. The results were processed in terms of the distri-
bution of relaxation rate. As shown in Fig. 8, a typical spec-
trum exhibits a sequence of peaks with different amplitudes.
Two parameters were used to characterized the ocular tissues
under test: ~1! the abscissa G @max, measuring position# of the
peak at the maximum amplitude and ~2! the center of gravity
of the relaxation rate distribution, abscissa G ~g, measuring
position!. Metabolic changes that were due to diabetic retin-
opathy were observed using both DLS in the corneal tissue
and corneal autofluorescence. High sensitivity and specificity
could be obtained from corneal autofluorescence and G @g,
cornea#, by fixing a proper threshold to discriminate negli-
gible ~grade 1! from background diabetic retinopathy ~grade
2!. These two parameters are not suitable for assigning a dia-
betic retinopathy grade, since ~pre-! proliferative diabetic ret-
inopathy ~grade 3! could easily be confused with negligible
diabetic retinopathy ~grade 1!.Journa
Downloaded from SPIE Digital Library on 25 Mar 2010 The increase in the corneal autofluorescence between pa-
tients with negligible diabetic retinopathy ~grade 1! and those
with background diabetic retinopathy ~grade 2! was associ-
ated with a marked decrease in the mean value of G @g, cor-
nea#. This could be due to a metabolic disorder that results in
an increase in the mean radius of the scattering molecules.
However, it could also be related to a decrease in the molecu-
lar mobility, due for example, to an increase in the local vis-
cosity or to interactions among scattering centers. Note that
the decrease in the corneal autofluorescence between patients
with background diabetic retinopathy ~grade 2! and those with
~pre-! proliferative diabetic retinopathy ~grade 3! is associated
with an increase in G @g, cornea# in the cornea. As shown in
Fig. 9~a!, the high correlation between corneal autofluores-
cence mean values and G @g, cornea# demonstrates that
changes in autofluorescence are induced by a structural
change in the corneal tissue.57
Glycosylation of the hyaluronate molecules as well as the
presence of pathological plasma proteins, which may occur
with a partial breakdown of the blood-retinal barrier ~BRB!
during the course of diabetes mellitus, alters the tertiary and
quaternary structure of the vitreous molecules as well as their
diffusivity. Such changes are known from other tissues.58 In
the vitreous they can be detected by DLS at a time when there
is no visible alteration and no onset of diabetic retinopathy.
Because the breakdown of BRB causes significant changes in
protein concentration in the vitreous first and then alterations
of the corneal tissue, DLS in the vitreous should be more
effective for an early detection of diabetic retinopathy.
It may be assumed that alterations that are due to diabetic
retinopathy show up in the vitreous before the cornea because
of the close spatial location of the vitreous and the retina. The
increase of the G @max, vitreous# in patients with negligible
diabetic retinopathy ~grade 1! and those with background dia-
betic retinopathy ~grade 2! could be due to alteration of the
tertiary and quaternary structure of the vitreous molecules as
well as their diffusivity. As shown in Fig. 9~b!, even the mean
value of G @max, vitreous# significantly correlates with cor-
neal autofluorescence, confirming that the two phenomena are
strictly connected.57
Patients affected by open-angle glaucoma often have to use
intraocular pressure ~IOP!-lowering medication for several
years. As Van Best has correctly stated, timolol is one of theFig. 8 Typical spectrum of the relaxation rate obtained performing
dynamic light-scattering measurements in the vitreous body. (Repro-
duced from Ref. 57 with permission.)l of Biomedical Optics d January/February 2004 d Vol. 9 No. 1 17
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Rovati and DocchioFig. 9 (a) G[g, cornea] versus corneal autofluorescence in each dia-
betic retinopathy grade. (b) G[max, vitreous] versus corneal autofluo-
rescence in each diabetic retinopathy grade. The solid squares and
bars represent the mean value and the standard error of the mean in
the three diabetic retinopathy groups considered in the study per-
formed by Rovati et al. (Reproduced from Ref. 57 with permission.)most frequently prescribed eyedrops in the treatment of IOP.
It can cause corneal epithelial cell damage in healthy
subjects,59–61 as demonstrated in open-angle glaucoma and
ocular hypertension patients62 by measurement of corneal
autofluorescence.47 As shown in Fig. 10, the corneal epithelial
permeability and thus the autofluorescence values of patients
using timolol as well as those of patients not using timolol
were significantly higher than those of healthy controls ~mean
increase, 40 and 21%, respectively; Mann-Whitney test, P
50.002).
The 40 and 21% increase in the values of corneal autof-
luorescence in open-angle glaucoma or ocular hypertension
patients compared with those of healthy controls indicate, as
Van Best stated, an increase in corneal metabolism associated
with the disease, but apparently not with the daily instillation
of timolol. The reasons for the alterations in corneal metabo-
lism that occur in glaucoma remain speculative. One explana-
tion might be the appearance of an autonomic neuropathy,
which has been suggested as an etiological factor in the patho-
genesis of glaucoma.63–66 An autonomic neuropathy may
change corneal innervation and consequently alter corneal
metabolism.
In penetrating keratoplasty corneas, the corneal metabo-
lism can be influenced by the surgical denervation of the18 Journal of Biomedical Optics d January/February 2004 d Vol. 9 No.
Downloaded from SPIE Digital Library on 25 Mar 2010 cornea.67–69 This may contribute to the changes measured in
corneal autofluorescence since other factors such as recipi-
ent’s age, donor age, and total lifespan of the transplant did
not influence the corneal autofluorescence.47
4.2 Lens Autofluorescence
Studies on the transmission and autofluorescence properties of
ocular media have been performed using ASF. The transmis-
sion of the lens in relation to aging and pathology is being
consistently studied by several groups.70–72
As shown in Fig. 11, the fluorescence of the lens has been
found to increase linearly with age in healthy individuals.73
Strong indications were found that the UV or UVA radiation
in sunlight was responsible for this increase.74–76 With age,
transmission of blue light decreases, whereas the transmission
of green to red light is less modified.
The correlation between autofluorescence of the human
lens and diabetes mellitus has been investigated over the past
three decades.77 One of the most provocative results of this
technique is its apparent ability to detect a prediabetic condi-
tion when no other symptoms are present. Lens autofluores-
cence in diabetic patients was found to be related to metabolic
regulation78 and to increase twice as fast as that in healthy
individuals.79 The correlation between the fluorescence ratio
and the invasive hemoglobin A1C test results has been dem-
onstrated. Unfortunately a large dependence of the lens autof-
luorescence on the subject’s age has been observed and
therefore an age correction for the data obtained from
autofluorescence measurements is essential. This correction is
critical since the model used to describe the dependence of the
fluorescence ratio and age introduces a statistical spread of the
measured data.
The initial stages of cataract are characterized by the ap-
pearance of lipid fluorophores in the near-ultraviolet and vio-
let regions of the spectrum, whereas in advanced stages an
increase in the intensity of the long-wave fluorescence of the
lipids in the blue-green region occurs.80 It has been proposed
that the decreased transmission of visible light in the aging
lens and in nuclear cataract is mainly due to the accumulation
Fig. 10 Corneal epithelial permeability evaluated by autofluores-
cence measurements on open-angle glaucoma and ocular hyperten-
sion patients as a function of age. Solid and open squares represent
patients not using and patients using timolol medication, respectively.
The straight and broken lines represent the mean value and the 95%
probability range of healthy control values, shown as solid triangles.
(Reproduced from Ref. 22 with permission.)1
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Autofluorescence methods in ophthalmologyFig. 11 Typical lens autofluorescence curves of healthy individuals aged (a) 7 years, (b) 53 years, and (c) 84 years. Maximum autofluorescence
increases and lens transmission index decreases with age. Note different scale in (a) (Reproduced from Ref. 73 with permission.)of lens fluorogens rather than configurational changes of the
lens proteins, as seen in cortical cataracts. The lens fluorogens
are responsible, to a significant degree, for the increasing yel-
low color of the lens with age. The nuclear and perinuclear
cortical regions of the lens show the most intense blue-green
autofluorescence, which may be derived from a UV light-
induced tryptophan photodegradation reaction or caused by
nonenzymatic glycosylation of the lens proteins.
In cataractous lenses, the mean autofluorescence and scat-
ter values are statistically significantly different from those of
age-matched healthy controls. Many investigators have pro-
posed a UV light-induced photo-oxidative mechanism for
cataract formation. In part, the low glutathione concentration
in the lens nucleus makes it particularly vulnerable to long-
term photo-oxidative stress following crystallin aggregation,
pigmentation, and development of nontryptophan fluores-
cence. Measurements of corneal and lens autofluorescence
will be of particular interest because of their clear association
with morphological and biochemical changes in these
tissues.57
4.3 Autofluorescence of Retinal Pigment Epithelium
Lipofuscin is a fluorescent pigment that is absent in fetal and
newborn RPEs; it continuously accumulates in the RPE as a
result of incomplete digestion of spent rod outer segment
disks.81–86 An increase of about 40% in the fluorescence in-
tensity of lipofuscin is observed with increasing age.86 There-
fore lipofuscin is commonly considered as an indicator of
aging. Retinal pathologies such as age-related maculopathy
~ARM!, senile macular degeneration ~SMD!, retinitis pigmen-
tosa ~RP!, and retinal abnormalities related to the Sjo¨gren-
Larsson syndrome ~SLS!, all exhibit abnormal content and
distribution of lipofuscin.82,87–88
Spaide89 recently showed that there is no correlation be-
tween autofluorescence measurements and the degree of
nuclear sclerosis (P50.14), whereas patients with exudative
AMD had more autofluorescence in the fellow eye than did
patients without a history of exudative AMD (P50.002). Pa-
tients with retinal vascular anastomosis have focal areas of
intense autofluorescence in their fellow eye that corresponded,
for the most part, to focal areas of hyperpigmentation best
seen by infrared monochromatic fundus photography (PJourna
Downloaded from SPIE Digital Library on 25 Mar 2010 50.015). These findings suggest possible explanations for
certain patterns of vessel growth seen in exudative AMD.
RPE autofluorescence was used to study lipofuscin distri-
bution associated with individual drusen in patients with
ARM or SMD.90 A specific pattern of autofluorescence was
frequently found to be spatially associated with hard drusen
and soft drusen between 60 and 175 mm in size. The pattern is
characterized by a central area of decreased autofluorescence
surrounded, in most cases, by an annulus of increased autof-
luorescence. The location of this pattern was highly correlated
with the position of individual distinct drusen. The central low
autofluorescence focus was on average 16% below the sur-
rounding background, and the annulus, when present, was on
average 6% more fluorescent than the background.
5 Conclusions and Outlook
Ocular fluorometry, alone or in combination with other optical
methods of investigation of the ocular media, has reached full
maturity, and this is due primarily to considerable efforts in
the investigation of fluorophores and their relation to age and
pathologies in the eye, and to the dramatic improvement in
optical and electro-optical components and devices. The high
social relevance of diagnostic instruments for population
screening, and the increase in the average age of a modern
population ~stressing the importance of careful treatment of
age-related pathologies to maintain an adequate quality of life
in the elderly! are indicators of the fact that the near future
will bring us new, sophisticated instruments for rapid, timely,
noninvasive diagnoses in ophthalmology where fluorometry
can play a significant role.
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